ArticleThe Indian journal of radiology & imaging2026
Ultrafast MRI in BI-RADS 4 Masses: The Fast Lane to Clarity.
Article in The Indian journal of radiology & imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to evaluate the diagnostic accuracy of ultrafast magnetic resonance imaging (UF-MRI)-derived kinetic parameters in differentiating benign from malignant BI-RADS (Breast Imaging-Reporting and Data System) 4 breast masses. It also compares the performance of UF-MRI with standard dynamic contrast-enhanced MRI (DCE-MRI) to determine its impact on clinical decision-making and overall diagnostic accuracy. Materials and Methods: This cross-sectional observational study included patients with BI-RADS 4 breast masses who underwent UF-MRI from January to December 2024. UF-MRI was acquired continuously over a brief period, capturing kinetic parameters including time to enhancement (TTE), arterial-venous interval (AVI), and maximum slope (MS), in addition to standard DCE-MRI. Two radiologists with more than 10 years of experience in breast radiology independently evaluated the results from standard DCE-MRI and UF-MRI. Statistical analysis assessed the correlation between UF-MRI parameters, standard DCE-MRI, and final histopathology. Results: A total of 31 breast masses from 29 patients (mean age: 45.3 ± 10.9 years) were evaluated, with 16 malignant and 15 benign masses confirmed on histopathology. UF-MRI parameters TTE and AVI demonstrated a strong correlation with malignancy (Cramer's V: 0.81 and 0.87, Conclusion: UF-MRI offers a fast and accurate approach for distinguishing benign from malignant BI-RADS 4 lesions, with TTE and AVI emerging as highly reliable diagnostic markers. It addresses the limitations of standard DCE-MRI by providing early contrast wash-in dynamic data with shorter acquisition times and higher specificity. Integrating UF-MRI kinetic parameters with morphological characteristics such as shape and margins can significantly enhance diagnostic precision, especially in patients with dense breasts and multiple masses, thereby minimizing the need for unnecessary biopsies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.